"description","label","name","uuid:ID","instanceType","text","id"
"Main objective","","OBJ1","d4fea44e-15d6-44be-82f6-aed305c34b88","OBJECTIVE","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg]).","Objective_1"
"Safety","","OBJ2","39eca0e0-d63e-47c1-bfc8-4a76ebb292a9","OBJECTIVE","To document the safety profile of the xanomeline TTS.","Objective_2"
"Behaviour","","OBJ3","4c10d0c3-10bf-47b7-bd37-91ad5fcb6b7a","OBJECTIVE","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas.","Objective_3"
